Cite
HARVARD Citation
Kong, J. et al. (2017). Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia?. Cancer. 123 (13), pp. 2482-2488. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kong, J. et al. (2017). Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia?. Cancer. 123 (13), pp. 2482-2488. [Online].